jRCT2080223387未知3 期
A Randomized, Parallel-Group, Double-Blind, Multicenter, Dose Equivalence Study of the Safety and Efficacy of Oral Lubiprostone in Subjects with Chronic Idiopathic Constipation
试验速览
- 阶段
- 3 期
- 入组人数
- 134
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Randomized, Parallel-Group, Double-Blind, Multicenter
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Subject has history of constipation, on average, less than 3 spontaneous bowel movements per week for at least 6 months before the start of screening and during the baseline period.
排除标准
- 未提供
结局指标
主要结局
-
Change from baseline in the frequency of spontaneous bowel movements at week 1
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
A Randomized, Parallel-Group, Double-Blind, Multicenter, Dose Equivalence Study of the Safety and Efficacy of Oral Lubiprostone in Subjects with Chronic Idiopathic ConstipatioChronic Idiopathic ConstipationJPRN-jRCT2080223387Sucampo Pharma, LLC134
进行中（未招募）
不适用
A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess Glycemic Control with Rimonabant in Comparison with Glimepiride over 1 Year in Overweight/Obese Type 2 Diabetic Patients Not Adequately Controlled with Metformin - ALLEGROOverweight/Obese Type 2 Diabetic Patients Not Adequately Controlled with MetforminMedDRA version: 8.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2006-005385-39-HUsanofi-aventis recherche et developpement500
终止
3 期
Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-Epileptic Drugs (AEDs) in Patients With Epilepsy.Epilepsy SeizuresNeurological - EpilepsyACTRN12609000600246Ortho-McNeil Janssen Scientific Affairs, LLC600
进行中（未招募）
不适用
A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess Glycemic Control with Rimonabant in Comparison with Glimepiride over 1 Year in Overweight/Obese Type 2 Diabetic Patients Not Adequately Controlled with Metformin - ALLEGROEUCTR2006-005385-39-FIsanofi-aventis recherche et developpement500
已完成
3 期
A Glycemic Control Evaluation of Glimepiride versus Rimonabant on Top of Metformin in Type 2 DiabetesCTRI/2008/091/000040SanofiSynthelabo IndiaLtd500